CLINICAL_TRIALS
trial_result
· 2012-04-03
Clinical Trial Update: Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer [Phase 2]
Summary
A Phase 2 trial of AG-013736 (axitinib) in patients with refractory metastatic renal cell carcinoma has completed, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Kidney Neoplasms, Carcinoma, Renal Cell | Phase 2 | Status: COMPLETED | Results posted: 2012-04-03